# mitox-protocol

Power calculations and sample size estimates associated with the clinical trial protocol, "A Pilot Study of the Effect of the Microbiome on Immune Checkpoint Inhibitor Response in Melanoma (OSU-19125)". 

If you use the code in this repository, please cite: 

Spakowicz, D., and Muniak, M. (2019). spakowiczlab/mitox-protocol: IRB submission (Zenodo).

[![DOI](https://zenodo.org/badge/190498356.svg)](https://zenodo.org/badge/latestdoi/190498356)

The goal of the study is to predict which melanoma patients will respond to immunotherapy or experience immune-related adverse events using microbiome samples and other biomarkers. 

This work is supported by Pelotonia
<img src="mitox-pelotonia-1.png" width="400" height="400">

Background image credit: Image Credit: Darryl Leja, NHGRI
